drug protocol number

Version 1.3.1

drug sponsor

Abbvie Biopharmaceuticals GmbH / KSU Liver Disease Research Center

drug study

ombitasvir \ paritaprevir \ ritonavir

drug trial site

NGHA-J

drug status

Ongoing

drug phase